Equities

Shanrong Biotechnology Corp

SRBT:PKC

Shanrong Biotechnology Corp

Actions
  • Price (USD)0.485
  • Today's Change0.00 / 0.00%
  • Shares traded358.00
  • 1 Year change--
  • Beta-3.0727
Data delayed at least 15 minutes, as of Aug 30 2024 16:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2009200920082007
OPERATIONS
Net income(5.08)(2.72)(0.05)
Depreciation/depletion0.040.04--
Non-Cash items3.380.150
Cash taxes paid, supplemental000
Cash interest paid, supplemental0.030.080
Changes in working capital0.871.080.03
Total cash from operations(0.79)(1.45)(0.02)
INVESTING
Capital expenditures00.00(0.01)
Other investing and cash flow items, total------
Total cash from investing00.00(0.01)
FINANCING
Financing cash flow items0(0.03)--
Total cash dividends paid------
Issuance (retirement) of stock, net0.640.400.08
Issuance (retirement) of debt, net0.121.11--
Total cash from financing0.761.480.08
NET CHANGE IN CASH
Foreign exchange effects----0.00
Net change in cash(0.03)0.030.05
Net cash-begin balance/reserved for future use0.060.040
Net cash-end balance/reserved for future use0.030.060.05
SUPPLEMENTAL INCOME
Depreciation, supplemental0.040.04--
Cash interest paid, supplemental0.030.080
Cash taxes paid, supplemental000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.